AMGEN EUROPE GMBH has a total of 24 patent applications. Its first patent ever was published in 2003. It filed its patents most often in Australia, EPO (European Patent Office) and Hungary. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are ERIMOS PHARMACEUTICALS LLC, CHELSEA THERAPEUTICS INC and INST MEDIZINTECHNOLOGIE MAGDEB.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 10 | |
#2 | EPO (European Patent Office) | 7 | |
#3 | Hungary | 2 | |
#4 | Canada | 1 | |
#5 | Republic of Korea | 1 | |
#6 | Netherlands | 1 | |
#7 | Serbia | 1 | |
#8 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Venkateswaralu Jasti | 5 |
#2 | Schafer Peter H | 5 |
#3 | Reddy Nallamaddi Ravikumar | 5 |
#4 | Muller George W | 5 |
#5 | Rajendiran Chinnapillai | 5 |
#6 | Connolly Terrence Joseph | 4 |
#7 | Kelly Michael T | 4 |
#8 | Ruchelman Alexander L | 4 |
#9 | Frank Anthony Joseph | 4 |
#10 | Bhat Sreenivas S | 4 |
Publication | Filing date | Title |
---|---|---|
AU2019229583A1 | Methods and compositions of isoindoline-1,3-dione and isoindole prodrugs useful for treating cancer, ulcerative colitis and related inflammatory diseases | |
AU2014265073A1 | Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof | |
AU2012205809A1 | Phenethylsulfone isoindoline derivatives as inhibitors of PDE 4 and/or cytokines |